A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain

• Status: Completed
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This non-interventional, observational study is set up on request of the Belgian reimbursement authorities and evaluates the efficacy of Targinact with regard to pain relief and constipation in daily clinical practice in Belgium compared to the previous analgesic treatment with prolonged release oxycodone. Only patients eligible for Targinact® reimbursement in Belgium are included.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mundipharma CVA
• Treatments: Naloxone; Oxycodone

Criteria

Inclusion criteria: patients included are patients who

• are eligible for Targinact® treatment according to the Targinact® SPC AND

• who have previously been treated with PR oxycodone during at least the last 30 days before study inclusion AND

• who are constipated (BFI > 30) AND

• have used at least 2 laxatives with different modes of action during the previous PR oxycodone treatment

Exclusion criteria are based on Targinact® SPC.